Online citations, reference lists, and bibliographies.
← Back to Search

Design And Characterization Of Chitosan Nanoformulations For The Delivery Of Antifungal Agents

Natalia L. Calvo, S. Sreekumar, L. Svetaz, M. C. Lamas, B. Moerschbacher, D. Leonardi
Published 2019 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Among different Candida species triggering vaginal candidiasis, Candida albicans is the most predominant yeast. It is commonly treated using azole drugs such as Tioconazole (TIO) and Econazole (ECO). However, their low water solubility may affect their therapeutic efficiency. Therefore, the aim of this research was to produce a novel chitosan nanocapsule based delivery system comprising of TIO or ECO and to study their suitability in vaginal application. These systems were characterized by their physicochemical properties, encapsulation efficiency, in vitro release, storage stability, cytotoxicity, and in vitro biological activity. Both nanocapsules loaded with TIO (average hydrodynamic size of 146.8 ± 0.8 nm, zeta potential of +24.7 ± 1.1 mV) or ECO (average hydrodynamic size of 127.1 ± 1.5 nm, zeta potential of +33.0 ± 1.0 mV) showed excellent association efficiency (99% for TIO and 87% for ECO). The analysis of size, polydispersity index, and zeta potential of the systems at 4, 25, and 37 °C (over a period of two months) showed the stability of the systems. Finally, the developed nanosystems presented fungicidal activity against C. albicans at non-toxic concentrations (studied on model human skin cells). The results obtained from this study are the first step in the development of a pharmaceutical dosage form suitable for the treatment of vaginal candidiasis.
This paper references
10.1016/j.msec.2015.10.035
Spray-dried powders improve the controlled release of antifungal tioconazole-loaded polymeric nanocapsules compared to with lyophilized products.
R. F. Ribeiro (2016)
10.1016/S0010-7824(99)00010-4
A vaginal fluid simulant.
D. Owen (1999)
10.1016/j.ijpharm.2015.09.015
Novel drug delivery strategies for improving econazole antifungal action.
A. Firooz (2015)
10.1211/jpp/61.05.0003
Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate.
N. Passerini (2009)
10.1371/journal.pone.0062500
A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach
S. Vicente (2013)
10.1016/j.ijpharm.2018.12.011
Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis.
Natalia L. Calvo (2019)
10.1016/j.ijbiomac.2016.05.054
Why Chitosan? From properties to perspective of mucosal drug delivery.
A. Kumar (2016)
10.1155/2013/204237
Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents
C. Spampinato (2013)
10.1063/1.1603731
Fractal kinetics in drug release from finite fractal matrices
K. Kosmidis (2003)
10.1166/JNN.2006.429
Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness.
C. Prego (2006)
10.1016/S1773-2247(06)50061-9
Chitosan nanocapsules: a new carrier for nasal peptide delivery
C. Prego (2006)
10.1016/J.JDDST.2018.11.023
Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery
S. Deshkar (2019)
10.1021/bm1004838
Chitosan in nanostructured thin films.
F. Pavinatto (2010)
10.1002/EM.20278
Biodegradation of benzo[a]pyrene with immobilized laccase: Genotoxicity of the products in HaCat and A3 cells
Xiaoke Hu (2007)
Emulsion Stability and Testing
(2011)
10.1016/s0003-2670(97)89601-8
Analytical Profiles Of Drug Substances And Excipients
L. Jaeger (2016)
Chitosan based drug delivery systems
A. Piegat (2016)
10.1007/978-3-0348-7161-7_3
Antifungal chemotherapy.
P. Hoeprich (1995)
10.1007/s11095-006-9570-8
Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
C. Prego (2006)
10.1016/j.msec.2014.05.001
Structural analysis of chitosan hydrogels containing polymeric nanocapsules.
R. V. Contri (2014)
10.1111/j.2042-7158.1978.tb13253.x
On methods of expressing dissolution rate data
J. A. Goldsmith (1978)
10.1016/J.COLSURFA.2016.09.086
Chitosan-coated dapsone-loaded lipid-core nanocapsules: Growth inhibition of clinical isolates, multidrug-resistant Staphylococcus aureus and Aspergillus ssp.
Rodrigo Cé (2016)
10.1021/bm800298u
Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.
M. Lozano (2008)
10.1016/j.ijpharm.2015.01.051
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.
F. Danhier (2015)
10.1208/s12249-012-9894-0
Design, Characterization, and In Vitro Evaluation of Antifungal Polymeric Films
D. Real (2012)
10.1016/J.DET.2007.01.002
Advances in topical and systemic antifungals.
A. Zhang (2007)
Método de dilución en medio líquido. In Manual de Técnicas in vitro para la detección de compuestos antifúngicos
L Rodero (2007)
Método de dilución en medio líquido
L. Rodero (2007)
10.1208/pt0804109
Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections
M. A. Alam (2008)
10.1016/J.IJPHARM.2005.10.044
On the use of the Weibull function for the discernment of drug release mechanisms.
V. Papadopoulou (2006)
10.1111/j.2042-7158.1972.tb08930.x
Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution
F. Langenbucher (1972)
10.1007/S003960050050
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
10.1128/CMR.00076-09
Candida Infections of the Genitourinary Tract
J. Achkar (2010)
10.1208/s12248-010-9185-1
DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles
Y. Zhang (2010)
10.1016/j.actbio.2016.08.018
Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
A. Machado (2016)
10.1016/S1461-5347(00)00255-8
Therapeutic applications of colloidal drug carriers.
Barratt (2000)
10.1039/C2SM26959G
An algorithm to determine the mechanism of drug distribution in lipid-core nanocapsule formulations
C. P. D. Oliveira (2013)
10.1016/S0065-7743(08)60376-0
Chapter 15 Antifungal Chemotherapy
J. Heeres (1980)
10.1021/MA060230J
Formation of New Glucomannan−Chitosan Nanoparticles and Study of Their Ability To Associate and Deliver Proteins
M. Alonso-Sande (2006)
10.5681/bi.2012.011
Nanocapsules: the weapons for novel drug delivery systems.
Pavankumar Kothamasu (2012)
10.1016/j.ejpb.2014.02.003
Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
E. Schultze (2014)
10.1016/j.nano.2011.10.014
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer.
D. Vergara (2012)
10.1016/J.COLSURFA.2017.03.041
Lutein-loaded lipid-core nanocapsules: Physicochemical characterization and stability evaluation
A. Brum (2017)
10.1016/j.ijbiomac.2017.12.078
A review on chitosan and its nanocomposites in drug delivery.
A. Ali (2018)
10.1016/j.biopha.2017.10.020
Tretinoin-loaded lipid-core nanocapsules overcome the triple-negative breast cancer cell resistance to tretinoin and show synergistic effect on cytotoxicity induced by doxorubicin and 5-fluororacil.
E. Schultze (2017)
Antifungal Chemotherapy. In Annual Reports in Medicinal Chemistry
J. Heeres (1980)
Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition
Clsi (2008)
10.1016/j.ijbiomac.2014.05.033
Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis.
E. Cevher (2014)
10.1128/EC.00034-10
Adaptations of Candida albicans for Growth in the Mammalian Intestinal Tract
A. Rosenbach (2010)
10.1016/j.ijpharm.2010.03.002
Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18.
J. Pardeike (2010)
10.1371/journal.pone.0207625
Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations
D. Real (2018)
10.3390/ijms20020398
Nanostructured Chitosan-Based Biomaterials for Sustained and Colon-Specific Resveratrol Release
N. Iglesias (2019)
10.1198/tech.2003.s146
Model Selection and Multimodel Inference
S. Creel (2003)
10.3390/ijms13022405
Characterization of Different Functionalized Lipidic Nanocapsules as Potential Drug Carriers
Paola Sánchez-Moreno (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar